University of Pennsylvania researchers and The Chinese University of Hong Kong presented TD3B, an AI framework aimed at streamlining peptide drug design. The system generates peptide candidates while also predicting their biological effect on target receptors, addressing a key gap between sequence generation and functional activity forecasting. The approach was shared as a Spotlight at the 2026 International Conference on… (per the provided item) and underscores a growing push toward “design with intent,” where candidate molecules are evaluated in silico for mechanism-relevant properties before synthesis. If validated broadly, receptor-effect prediction could shorten peptide hit-to-lead cycles and improve the quality of candidates entering early development, particularly for receptor-mediated indications where pharmacology is tightly linked to binding and downstream signaling.